Amgen, one of the world's leading biotechnology companies, opened an office in South Korea in November, 2015, in order to make its innovative medicines available to Korean patients suffering from serious illnesses. Amgen’s entry into Korea will bring more clinical trials and innovative therapies for grievous illnesses to patients in Korea. Amgen also looks forward to being an active member of the local biotechnology community and helping to advance the growth of this industry in Korea.
Thank you for your interest in Amgen Korea. Our Amgen Korea website is currently under construction; please check back to learn more about Amgen and Amgen’s interest in Korea. In the meantime, we invite you to visit Amgen’s corporate website at www.amgen.com
Amgen Korea Leadership
Sang Noh, General Manager